U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Animal & Veterinary
  3. Safety & Health
  4. FDA’s Public Meeting on Antiparasitic Drug Use and Resistance in Ruminants and Equines
  1. Safety & Health

FDA’s Public Meeting on Antiparasitic Drug Use and Resistance in Ruminants and Equines

The Office of New Animal Drug Evaluation (ONADE) at FDA’s Center for Veterinary Medicine held a public meeting entitled “Antiparasitic Drug Use and Resistance in Ruminants and Equines” on March 5 and 6, 2012.

The public meeting targeted industry and academic stakeholders interested in antiparasitic resistance in the United States. Meeting attendees explored and discussed ways antiparasitic drugs can be used, alone or in combination, to maximize drug effectiveness and minimize resistance in ruminants and equines.

Seven internationally recognized veterinary parasitology experts gave PowerPoint presentations on a range of topics related to antiparasitic resistance in the United States. FDA also invited the public to speak during the meeting’s two open comment periods. After the meeting, there was a 60-day open comment period for the public to submit comments to the FDA.

To navigate the meeting documents:

  • Click on the link for the docket at Regulations.gov.
  • Under “Browse Documents,” there are links to the meeting transcripts and presentations.
  • Under “Browse All Comments," there are links to the submitted public comments.

For questions or feedback about the public meeting, please contact the following ONADE staff:

Additional Information

Back to Top